# Daan Gene > Chinese company **Wikidata**: [Q10875261](https://www.wikidata.org/wiki/Q10875261) **Source**: https://4ort.xyz/entity/daan-gene ## Summary Daan Gene is a Chinese public company and a joint-stock enterprise based in the People's Republic of China. It was founded in 1988 and is listed on the Shenzhen Stock Exchange under the ticker symbol 002030. The company operates primarily in the biotechnology and diagnostics sector. ## Key Facts - Founded in 1988. - Legally incorporated as a public company (instance_of: business, public company). - Traded on the Shenzhen Stock Exchange with the stock code 002030. - Official website: [http://www.daangene.com/](http://www.daangene.com/) - Based in the People's Republic of China. - Also known by its Chinese name: 达安基因. - Identified in Crunchbase under the organization ID "daan-gene". - Unified Social Credit Identifier (China): 91440101190445368X. - Has a sitelink presence on one language version of Wikipedia: Chinese (zh). - Described on Wikidata as a "Chinese company". ## FAQs **What is Daan Gene?** Daan Gene is a publicly traded biotechnology company based in China. It specializes in the research, development, production, and sales of diagnostic products, primarily in the areas of molecular diagnostics and pathology. **When was Daan Gene founded?** Daan Gene was established in 1988. **Where is Daan Gene listed?** It is listed on the Shenzhen Stock Exchange, with the stock ticker symbol 002030. **What is Daan Gene's legal structure?** It is structured as a public company, a form of joint-stock enterprise, and is subject to public disclosure requirements in China. **What is Daan Gene's official website?** The company's official website is [http://www.daangene.com/](http://www.daangene.com/). **What is Daan Gene's Unified Social Credit ID?** Daan Gene's Unified Social Credit ID is 91440101190445368X, as registered in China. **Is Daan Gene a publicly traded company?** Yes, it is a publicly traded company, offering its shares on the Shenzhen Stock Exchange. **What is Daan Gene known for in Chinese?** In Chinese, the company is known as 达安基因. **Is Daan Gene listed on international platforms like Crunchbase?** Yes, it is listed on Crunchbase under the organization ID "daan-gene". ## Why It Matters Daan Gene plays a significant role in China's biotechnology and diagnostics industry. As a public company, it contributes to the development and commercialization of diagnostic technologies, particularly in molecular diagnostics, which are critical in healthcare and disease prevention. Its public listing allows it to raise capital for innovation and expansion, supporting both domestic and global health initiatives. The company also contributes to the transparency and growth of China’s healthcare sector through its compliance with public financial reporting standards. ## Notable For - Being one of the early publicly listed companies in China's biotech sector. - Specializing in molecular diagnostics and pathology services. - Having a long-standing presence in the industry since 1988. - Being listed on the Shenzhen Stock Exchange, a key platform for Chinese tech and biotech firms. - Operating under strict public disclosure requirements, ensuring transparency. - Holding a unique Unified Social Credit ID in China’s corporate registry. ## Body ### History Daan Gene was founded in 1988, establishing itself as a key player in the Chinese biotechnology and diagnostics industry. Over the years, it has evolved into a significant public company with a strong presence in molecular diagnostics. Its listing on the Shenzhen Stock Exchange under ticker 002030 has enabled it to access public capital markets for growth and innovation. ### Legal and Regulatory Framework As a public company, Daan Gene is subject to the regulations and reporting standards required of all publicly traded companies in China. It is registered with a Unified Social Credit ID (91440101190445368X), a unique identifier for legal entities in China. This registration ensures compliance with national standards and transparency in business operations. ### Stock Listing and Financial Presence Daan Gene is listed on the Shenzhen Stock Exchange, with the stock ticker symbol 002030. This listing allows the company to raise capital from public investors and contributes to its visibility in the financial markets. Its public status also means it is subject to regular financial disclosures and auditing standards. ### Corporate Identity and Online Presence The company operates under the name 达安基因 in Chinese and is known as Daan Gene in English. Its official website, [http://www.daangene.com/](http://www.daangene.com/), serves as a primary source of information for investors, partners, and clients. It is also registered on Crunchbase under the ID "daan-gene", providing visibility to international business databases. ### Geographic and Operational Scope Daan Gene is based in the People's Republic of China and operates primarily within the Chinese market. However, its products and services in molecular diagnostics have relevance to global health systems. The company's operations are aligned with national healthcare development strategies and international diagnostic standards. ### Industry and Innovation Daan Gene is notable for its focus on molecular diagnostics, a field that plays a critical role in modern medicine, particularly in disease detection and personalized healthcare. Its innovation in this area positions it as a key contributor to public health infrastructure in China. ### Governance and Structure As a public company, Daan Gene is governed by a board of directors elected by shareholders. This structure aligns with the standard corporate governance model, separating ownership from management to ensure accountability and strategic oversight. ### International Recognition and Data Presence Daan Gene is recognized in international databases such as Crunchbase and Wikidata. It is also documented in the Chinese Wikipedia, indicating its relevance in both domestic and global contexts. Its presence in these systems supports transparency and accessibility for researchers, investors, and partners.